# Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)

> **NCT00113945** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 360 (—)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Cinacalcet

## Key facts

- **NCT ID:** NCT00113945
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 360 (—)
- **Last updated:** 2013-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113945, "Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00113945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*